Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Phosphorus or phosphorus compound
Patent
1994-10-14
1997-03-18
Pak, John
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Phosphorus or phosphorus compound
424603, 424678, 424682, 424683, 424686, 424687, 424688, 424689, 424692, 424693, 424694, 424696, 424697, 514 23, 514 25, 514262, 514263, 514264, 514423, 514460, 514557, 514558, 514625, 514629, 514667, 514899, A61K 3116, A61K 31165, A61K 3306, A61K 3342, A61K 3113, A61K 31152
Patent
active
056120613
ABSTRACT:
A composition for the treatment of premenstrual syndrome comprising an effective amount of calcium, magnesium, an analgesic and a diuretic sufficient to reduce the symptoms of premenstrual syndrome.
REFERENCES:
patent: 4946679 (1990-08-01), Thys-Jacobs
patent: 5011688 (1991-08-01), Calam et al.
patent: 5155105 (1992-10-01), Jones et al.
patent: 5296241 (1994-03-01), Brimberg et al.
Premenstrual and Menstrual Symptom Clusters and Response to Calcium Treatment Psychopharmacology Bulletin, vol. 27, No. 2, 1991, (Dr. Jose Ma. J. Alvir. and Susan Thys-Jacobs) pp. 145-148.
Oral Magnesium Sucessfully Relieves Premenstrual Mood Changes. (Fabio Facchinetti, MD, Paola Borella, MD, Gragia Sances, MD, Loredana Fioroni, MD, Rossella Nappi, MD and Andrea Genazzani, MD, Obstetrics & Gynecology, vol. 78, No. 2, 1991, pp. 177-181.
The Effect of a Nutritional Supplement, Optivite for Women, on Premenstrual Tension Syndromes. (Fuchsn. Ph.D., Hakim and Abraham), Journal of Applied Nutrition, vol. 37, No. 1, 1985, pp. 1-11.
Clinician's Approach to the Diagnosis and Management of Premenstrual Syndrome (Susan B. Johnson, MD), Clinical Ob. and Gyn., vol. 35(3), 1992, pp. 637-657.
Calcium Supplementation in Premenstrual Syndrome (Susan Thys-Jacobs, Silvio Ceccarelli, Arlene Bierman, Henry Weismam et al.), J. Gen. Int. Med., vol. 4, 1989, pp. 183-189.
Caffiene-Containing Beverages, TotalFluid Consumption, and Premenstrual Syndrome (Annette MacKay Rossignol and Heinke Bonnlander, RN), Am. J. Public Health, 1990, p. 1106.
The Menstrual Cycle, Physiology, Reproductive Disorders and Infertility (Michael Ferin, Raphael Jewelewicz and Michelle Warren), Oxford University Press, New York, 1993, pp. 198-204 and 245-246.
The Effect of a Nutritional Supplement, Optivite for Women, on Premenstrual Tension Syndromes (Chakmakjian, Higgins and Abraham), J. Applied Nutrition, vol. 37(1), 1985, pp. 12-17.
Effect of a Nutritional Supplement on Premenstrual Symptomatology in Women with Premenstrual Syndrome: A double-Blind Longitudinal Study (London, Bradley, and Chiamori), Journal of the American College of Nutrition, vol. 10, No. 5, 1991, pp. 495-499.
LandOfFree
Composition and method for the treatment of premenstrual syndrom does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method for the treatment of premenstrual syndrom, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for the treatment of premenstrual syndrom will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1704338